Compendium of Evidence-informed Approaches to Improving Health Outcomes for People Living with HIV
Resource updated 03/04/2024
Resource updated 03/04/2024
Blog updated 06/30/2022
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 11/27/2023
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 02/28/2024
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
RWHAP Technical Assistance Provider updated on 02/27/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
The syndemic of opioid use disorder, HCV and HIV and stigma causes burdens on individuals and the system. Integrating siloed systems of care is critical to addressing this crisis. Overlapping cascades of care are key to understanding the empirical relationships of these diseases and opportunities to identify, prevent and co-treat.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
After language-specific outreach on getting a COVID-19 vaccination, project saw a high rate of vaccine uptake in Spanish-speaking patients (81%) compared to English-speaking patients (4%).
Resource (Conference Presentation) updated 09/14/2023
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
Guide to help ADAPs prepare for and manage emergencies in order to ensure continued access to HIV medications.
Resource updated 09/19/2023
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Facilitator guide to train consumers to understand performance data and empower them to partner with their health care providers. Disponible en español: Cómo asegurarse de que su atención médica relacionada al VIH sea la mejor posible.
Resource updated 03/12/2024